Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Marealis AS
Age
30–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
mild or moderate hypertension (systolic blood pressure 130 - 160 mmHg and diastolic blood pressure ≤ 100 mmHg)
age 30 - 75 years
body weight ≥ 60 kg
stable body weight
use of effective contraception in women of childbearing potential
You may not be if
body mass index ≥ 35
antihypertensive drug treatment, regular high dose NSAID treatment and the use of cyclosporine or tacrolimus
diabetes (type 1 and 2)
anemia, abnormal electrolytes, proteinuria, abnormal liver, kidney and thyroid function, clinically significant biochemistry, any other clinically significant hematology and/or biochemistry at the investigator's discretion
cardiovascular disease (myocardial infarction, unstable angina pectoris, coronary artery bypass graft, percutaneous transluminal coronary angioplasty, temporal ischemic attack within six months prior to screening) including stroke and congestive heart failure
secondary hypertension history of cancer or malignant disease within the past five years
any metabolic disease, gastrointestinal disorder or other clinically significant disease/disorder which in the investigator's opinion could interfere with the results of the study or the safety of the subjects
fish and other seafood allergies, citrus allergy, multiple food allergies
alcohol abuse
smokers and tobacco/snuff/nicotine users
consumption of food supplements targeted to blood pressure lowering within 30 days before randomization
pregnant and lactating mothers, women, planning for pregnancy during the study
participation in clinical trials 30 days prior to this study and participation in other clinical intervention
Clareo Health | Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp
